Silver-coated megaendoprostheses in a rabbit model—an analysis of the infection rate and toxicological side effects
Source abstract
Abstract
Deep infection of megaprostheses remains a serious complication in orthopedic tumor surgery. Despite the use of systemic and local antibiotic prophylaxis the reported infection rate is between 5% and 35%. Silver-coated medical devices proved their effectiveness in reducing infections. The objective of this study was to examine in vivo the antimicrobial efficacy and possible side-effects of a silver-coated megaprosthesis. In a first study, 30 rabbits (15 titanium versus 15 silver-coated Mutars-endoprostheses) were infected with Staphylococcus aureus. In a second study, toxicological side effects were analyzed in 10 rabbits with a silver-coated megaprosthesis. The silver group showed significantly (p<0.05) lower infection rates (7% versus 47%) in comparison with the titanium group. Measurements of the C-reactive-protein, neutrophilic leukocytes, rectal temperature and body weight showed significant (p<0.05) lower signs of inflammation in the silver group. The analysis of the silver concentration in blood (median 1.883ppb) and in organs (0.798-86.002ppb) showed elevated silver concentrations without pathologic changes in laboratory parameters and without histological changes of organs. In conclusion, the new silver-coated Mutars-megaprosthesis resulted in reduced infection rates without toxicological side effects, suggesting that this prosthesis might be a promising device in tumor surgery exhibiting antimicrobial activity.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Urbanism, Landscape, and Tourism Studies · Regional Development and Innovation · Regional Economic and Spatial Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (59)
Show source-provided references
1. Limb salvage surgery for primary bone sarcoma of the lower extremities10.1007/BF02303861 ↗
2. Long-term followup of uncemented tumor endoprostheses for the lower extremity10.1097/00003086-200107000-00024 ↗
3. Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur10.1302/0301-620X.76B2.8113272 ↗
4. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas10.2106/00004623-199508000-00003 ↗
5. KMFTR (Kotz modular femur tibia reconstruction system) modular tumor endoprosthesis system for the lower extremity10.1055/s-2008-1039620 ↗
6. 151 endoprosthetic reconstructions for patients with primary tumors involving bone
7. Etiology and results of tumor endoprosthesis revision surgery in 64 patients10.1097/00003086-199901000-00009 ↗
8. Rotationplasty-surgical treatment modality after failed limb salvage procedure10.1007/s004020000175 ↗
9. A modular femur-tibia reconstruction system10.3928/0147-7447-19861201-07 ↗
10. Segmental total knee arthroplasty after distal femoral resection for tumor10.1097/00003086-199307000-00036 ↗
11. Biocompatibility testing of a new silver-impregnated catheter in vivo10.1007/BF02561616 ↗
12. Brutel de la Riviere A, Dossche KM, Birnbaum DE, Hacker R. First clinical experience with a mechanical valve with silver coating. J Heart Valve Dis 2000;9(1):123–9; discussion 129–30.
13. In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter10.1177/088532829400900103 ↗
14. A randomized crossover study of silver-coated urinary catheters in hospitalized patients10.1001/archinte.160.21.3294 ↗
15. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients10.1053/jhin.2001.0938 ↗
16. Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves
17. von Eiff C, Proctor RA, Peters G. Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med 2001;110(4):63–4, 69–70, 73–6.10.3810/pgm.2001.10.1046 ↗
18. Brause BD. Infected orthopedic prostheses. In: Bisno AL, Waldrogel FA, editors. Infections associated with indwelling medical devices. Washington, DC: American Society for Microbiology; 1989.
19. Pathogenesis of infections due to coagulase-negative staphylococci10.1016/S1473-3099(02)00438-3 ↗
20. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs10.1378/chest.121.3.863 ↗
21. Herrmann · 1997
22. Two-stage revision for infected endoprostheses used in tumor surgery10.1097/00003086-200202000-00022 ↗
23. Historical review of the use of silver in the treatment of burns. I10.1016/S0305-4179(99)00108-4 ↗
24. Toxicological aspects of topical silver pharmaceuticals10.3109/10408449609012524 ↗
25. Chambers C, Proctor C, Kabler P. Bactericidal effect of low concentrations of silver. J Am Water Works Association 1962:208–216.10.1002/j.1551-8833.1962.tb00834.x ↗
26. In vivo efficacy of silver-coated fabric against Staphylococcus epidermidis
27. The effect of silver ions on the respiratory chain of Escherichia coli10.1139/m74-135 ↗
28. Efficacy of silver-coated medical devices10.1016/S0195-6701(98)90301-2 ↗
29. New processes for surface treatment of catheters10.1111/j.1525-1594.1994.tb02193.x ↗
30. Antibacterial activity of multilayer silver-copper surface films on catheter material10.1139/m93-134 ↗
31. A comparison of the effect of early insertion of standard latex and silver-impregnated latex foley catheters on urinary tract infections in burn patients10.1086/502038 ↗
32. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection10.1016/S0002-9343(98)00240-X ↗
33. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients10.1016/S0732-8893(00)00166-8 ↗
34. Reduction of bacterial colonization of triple-lumen catheters with antiseptic bonding in septic patients10.1097/00000542-199409001-00261 ↗
35. Study of a novel antiseptic-coated central venous catheter
36. Antimicrobial-coated/bonded and -impregnated intravascular catheters10.1345/aph.10416 ↗
37. Incidence of catheter colonization and catheter related infections with an antiseptic impregnated triple lumen catheter10.1097/00003246-199401000-00216 ↗
38. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients10.1016/S0934-8840(11)80203-3 ↗
39. Pin tract infections10.3928/0147-7447-19940501-11 ↗
40. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings
41. Subclavian hemodialysis catheter infections10.1086/647169 ↗
42. A large randomized clinical trial of a silver-impregnated urinary catheter10.1016/S0002-9343(99)80313-1 ↗
43. Severe generalized argyria secondary to ingestion of colloidal silver protein10.1046/j.1365-2230.2003.01214.x ↗
44. Scar-localized argyria secondary to silver sulfadiazine cream10.1067/S0190-9622(02)61574-9 ↗
45. Generalized argyrosis10.1055/s-2008-1065062 ↗
46. Determination of silver in blood, urine, and tissues of volunteers and burn patients10.1093/clinchem/37.10.1683 ↗
47. Tentative reference values for gold, silver and platinum10.1016/0048-9697(92)90219-I ↗
48. Argyria
49. Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine10.1097/00004630-199103000-00004 ↗
50. In vitro toxicity of topical antimicrobial agents to human fibroblasts10.1016/0022-4804(89)90069-3 ↗
51. Prosthetic heart valves with silver-coated sewing cuff fabric
52. Silver-coated prosthetic heart valve10.1016/S1010-7940(01)00675-3 ↗
53. Paravalvular leak and other events in silzone-coated mechanical heart valves10.1016/S0003-4975(01)03442-7 ↗
54. Analysis of the acute cytotoxicity of the Erlanger silver catheter10.1007/BF02561615 ↗
55. Silver coated materials for external fixation devices10.1016/S0142-9612(01)00198-3 ↗
56. Evaluation of the silver iontophoretic catheter in an animal model10.1016/S0142-9612(03)00185-6 ↗
57. Biocompatibility of silver-coated polyurethane catheters and silver-coated Dacron material10.1016/0142-9612(94)90028-0 ↗
58. Assessment of silver-coated urinary catheter toxicity by cell culture10.1007/BF00510526 ↗
59. Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement